Research Article

Adherence to Typical Antipsychotics among Patients with Schizophrenia in Uganda: A Cross-Sectional Study

Table 5

Factors associated with nonadherence to typical antipsychotic medications among patients with schizophrenia.

VariableBivariate logistic regressionMultivariate logistic regression
Crude odds ratio (95% confidence interval) valueAdjusted odds ratio (95% confidence interval) value

Age0.99 (0.95–1.03)0.724
Sex
 Female1
 Male0.67 (0.26–1.72)0.406
Marital status
 Single1
 Married/cohabiting1.13 (0.36–3.52)0.828
 Separated/divorced0.88 (0.27–2.89)0.836
Level of education
 NoneOmittedOmitted
 Primary8.21 (1.00–67.55)0.0507.36 (0.56–95.92)0.127
 Secondary10.06 (1.23–82.33)0.03110.99 (0.79–152.17)0.074
 Tertiary1 (ref)1
Area residence
 Rural1
 Urban0.94 (0.37–2.37)0.892
Poverty line
 Above11
 Below1.96 (0.77–4.95)0.1577.15 (1.39–36.67)0.018
Substance use
 No1
 Yes0.64 (0.20–2.06)0.458
Distance from the hospital1.02 (0.99–1.03)0.1081.01 (0.98–1.04)0.521
Presence of a comorbidity
 No11
 Ye1.78 (0.61–5.20)0.2932.05 (0.40–10.64)0.391
Insight for psychosis
 Good1
 Poor0.85 (0.29–2.51)0.772
Attitude towards typical antipsychotic
 Negative1
 Positive1.40 (0.48–4.11)0.538
Duration of treatment (in years)0.97 (0.91–1.04)0.456
Satisfaction with medication1.23 (0.77–197)0.379
Burdened by the number of pills
 No1
 Yes1.08 (0.42–2.81)0.868
Number of pills0.79 (0.60–1.04)0.0910.85 (0.52–1.38)0.511
Frequency of daily drug taking
 Once11
 Twice0.56 (0.21–1.52)0.2570.43 (0.08–2.18)0.308
 Three times0.27 (0.03–2.28)0.2320.36 (0.02–7.32)0.507
 Four or more times3.85 (0.22–65.71)0.3524.18 (0.08–228.96)0.483
Frequency of drug stoke out at the facility for patients’ medications
 Never1
 Rarely2.12 (0.20–21.88)0.529
 Sometimes1.64 (0.19–14.37)0.657
 Often1.42 (0.13–15.64)0.774
 Always2.77 (0.26–29.04)0.396
Level of social support from family and friends0.87 (0.56–1.37)0.559
Satisfaction with health workers’ explanations of drug use and side effects0.91 (0.65–1.28)0.595
Stop medications due to religious or cultural beliefs
 No1
 Yes1.27 (0.49–3.31)0.620
Loss of energy or drive
 No11
 Yes0.22 (0.09–0.59)0.0020.15 (0.03–0.81)0.028
Feeling unmotivated
 No11
 Yes0.41 (0.16–1.09)0.0732.18 (0.35–13.47)0.401
Day time sedation
 No11
 Yes0.59 (0.24–1.49)0.2661.59 (0.36–6.99)0.535
Too much sleep
 No1
 Yes0.84 (0.33–2.13)0.715
Muscle too stiff
 No1
 Yes1.42 (0.52–3.83)0.492
Shaking
 No1
 Yes0.61 (0.22–1.68)0.339
Jittery
 No1
 Yes0.63 (0.21–1.84)0.397
Akathisia
 No11
 Yes0.48 (0.13–1.74)0.2640.68 (0.12–3.94)0.671
Trouble waking up
 No1
 Yes0.95 (0.38–2.36)0.909
Vision problems
 No11
 Yes0.49 0.16–1.57)0.2330.42 (0.08–2.06)0.282
Dry mouth
 No1
 Yes0.88 (0.33–2.35)0.807
Drooling of saliva
 No1
 Yes0.89 (0.24–3.34)0.865
Memory problems
 No1
 Yes0.94 (0.38–2.36)0.901
Constipation
 No11
 Yes1.73 (0.66–4.57)0.2652.45 (0.59–10.13)0.217
Weight changes
 Decrease0.29 (0.06–1.54)0.1481.34 (0.18–9.85)0.772
 Increase0.60 (0.22–1.64)0.3186.66 (0.73–60.51)0.092
 No change11
Sexual arousal problems
 No1
 Yes1.06 (0.42–2.65)0.901
Menstrual changes
 No11
 Yes2.27 (0.77–6.67)0.1351.22 (0.26–5.60)0.798
Total number of side effects experienced0.89 (0.76–1.04)0.138